Use of Lilly's COVID-19 Antibody Drug in Hungary

Hungary has become the first European country where the authorities have granted authorisation to the emergency use of US drugmaker Eli Lilly's Covid-19 antibody drug bamlanivimab, the Hungarian Ministry of Human Resources said on Wednesday.

As the state news agency MTI reports, the National Institute of Pharmacy and Nutrition (OGYEI) earlier this month approved the use of bamlanivimab for the treatment of patients with mild and moderate cases of Covid-19 who are at risk of developing more serious forms of the disease, the ministry said in a statement.